[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338719-105":59,"doc-detail-338719-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","calcipotriol-as-a-daylight-photodynamic-therapy-enhancer-a-case-control-study","Calcipotriol as a daylight photodynamic therapy enhancer - a case-control study","","Actinic keratoses (AKs) are common sun-exposed skin lesions considered potential precursors to squamous cell carcinomas (SCCs). This observational case-control study assessed whether pre-treatment with 0.005% calcipotriol (CAL) improves outcomes when combined with daylight photodynamic therapy (DL-PDT). Twenty immunocompetent male patients with grade I–II AKs were randomized to CAL pre-treatment or moisturizing cream, then received three DL-PDT sessions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/calcipotriol-as-a-daylight-photodynamic-therapy-enhancer-a-case-control-study/338719/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/calcipotriol-as-a-daylight-photodynamic-therapy-enhancer-a-case-control-study/338719.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What condition does the study focus on?","Question",{"text":112,"@type":113},"The study focuses on actinic keratoses (AKs), which are common lesions on sun-exposed skin and considered potential precursors to squamous cell carcinomas (SCCs).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was calcipotriol used in the treatment approach?",{"text":117,"@type":113},"Patients in the case group received 14-day pre-treatment with 0.005% calcipotriol (CAL) ointment before daylight photodynamic therapy (DL-PDT).",{"name":119,"@type":110,"acceptedAnswer":120},"What outcome measure was used to evaluate treatment effects?",{"text":121,"@type":113},"The Actinic Keratosis Area Severity Index (AKASI) was used to score actinic damage at baseline, 3 months, and 6 months after treatment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338719,1791362494,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Dermatology Reports 2025; volume 17:10077  \nCalcipotriol as a daylight photodynamic therapy enhancer: a case-control study  \nBenedetta Sonego,1 Enrico Zelin,2 Serena Bonin,3 Tommaso Pozzebon,4* Giulia Bazzacco,1 Andrea Corio,1 Marina Agozzino,1 Dante Raffaele Caro Caposiena,1 Iris Zalaudek,1 Nicola di Meo1  \n1Dermatology Clinic, Maggiore Hospital, University of Trieste; 2Institute of Dermatology, Santa Maria della Misericordia University Hospital, Udine; 3Department of Medical Sciences, University of Trieste; 4Department of Medical, Surgical and Health Sciences, University of Trieste, Italy  \n*Present address: Policlinico Universitario Fondazione Agostino Gemelli, Rome, Italy  \nAbstract  \nActinic keratoses (AKs) are common skin lesions found on sun-exposed areas and are considered potential precursors to squamous cell carcinomas (SCCs) . This observational case-control study evaluates the efficacy of combining traditional daylight photodynamic therapy (DL-PDT) with pre-treatment using 0.005%  \nCorrespondence: Benedetta Sonego, Maggiore Hospital, University of Trieste, Piazza dell’Ospitale 1, 34125 Trieste, Italy.  \nTel.: +39.0403992056.  \nE-mail: [benedetta.sonego@gmail.com](benedetta.sonego@gmail.com)  \nKey words: actinic keratoses; photodynamic therapy; calcipotriol.  \nContributions: BS, study design, conceptualization, methodology, patient recruitment, database creation, writing, extraction of data; EZ, manuscript review; SB, statistical analysis; TP, database creation, data curation; DRCC, MA, manuscript review, patient recruitment; GB, AC, patient recruitment; IZ, supervision; NdM, supervision, patient recruitment, manuscript review. All the authors have read and approved the final version of the manuscript and agreed tobe accountable for all aspects of the work.  \nConflict of interest: the authors declare no potential conflict of interest. Ethics approval and consent to participate: the study was approved by the University Ethics Committee of the University of Trieste in the session on 24th October 2023 (report n. 135) .  \nConsent for publication: the patients gave their written consent to use their personal data for the publication of this study and any accompanying images.  \nAvailability of data and materials: the datasets used and/or analyzed during the current study are available upon reasonable request from the corresponding author.  \nReceived: 1 July 2024.  \nAccepted: 9 August 2024.  \nThis work is licensed under a Creative Commons AttributionNonCommercial 4.0 International License (CC BY-NC 4.0) .  \n©Copyright: the Author(s), 2024  \nLicensee PAGEPress, Italy Dermatology Reports 2025; 17:10077 doi:10.4081/dr.2024.10077  \nPublisher's note: all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and thereviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.  \ncalcipotriol (CAL) ointment. Twenty immunocompetent male patients with grade I-II AKs on the scalp and/or face were randomized into two groups: the case group received a 14-day pre-treatment with CAL ointment before DL-PDT, while the control group used a moisturizing cream. Both groups underwent a series of three DL-PDT sessions. The study utilized the Actinic Keratosis Area Severity Index (AKASI) scoring system to measure the actinic damage at baseline, 3 months, and 6 months post-treatment. Results showed a significant reduction in AKASI scores in the CAL group compared to controls, indicating that CAL pretreatment enhances the efficacy of DL-PDT. This combination treatment was well tolerated, with minimal discomfort reported. The findings suggest that incorporating CAL into the treatment regimen can improve the clearance of AKs and potentially prevent their progression to SCCs.  \nIntroduction  \nActinic keratoses (AKs) are a common skin dis","cbCaitHsH6511NjR","https://ap.wps.com/l/cbCaitHsH6511NjR","pdf",4799602,"English","# Abstract\n# Introduction\n## Actinic keratoses and field cancerization\n## Photodynamic therapy and its rationale\n## Calcipotriol as a treatment enhancer","[{\"question\":\"What condition does the study focus on?\",\"answer\":\"The study focuses on actinic keratoses (AKs), which are common lesions on sun-exposed skin and considered potential precursors to squamous cell carcinomas (SCCs).\"},{\"question\":\"How was calcipotriol used in the treatment approach?\",\"answer\":\"Patients in the case group received 14-day pre-treatment with 0.005% calcipotriol (CAL) ointment before daylight photodynamic therapy (DL-PDT).\"},{\"question\":\"What outcome measure was used to evaluate treatment effects?\",\"answer\":\"The Actinic Keratosis Area Severity Index (AKASI) was used to score actinic damage at baseline, 3 months, and 6 months after treatment.\"}]","Calcipotriol as a daylight photodynamic therapy enhancer - a case-control study | PDF",1790025254,13,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec654614b097a69d515ccdf44760be94.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c009f3eb6cfa21dee5669c589baa9c3.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85e62bf53b11ccd2720933baf5890266.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ec53ea1f0b11e5019842fe84038b27c.webp",980,1306]